Moderna
MRNA
#1624
Rank
NZ$22.12 B
Marketcap
NZ$56.62
Share price
-5.50%
Change (1 day)
-19.17%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$22.12 Billion

As of December 2025 Moderna has a market cap of NZ$22.12 Billion. This makes Moderna the world's 1624th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$22.12 B-19.21%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Dec 22nd, 2025 the market cap of Moderna was reported to be:

NZ$23.40 Billion
by Nasdaq info icon info icon
NZ$23.41 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
NZ$0.96 B-95.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$448.97 B 1,929.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$1.43 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$90.56 B 309.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$457.99 B 1,970.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
NZ$16.50 B-25.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$850.54 B 3,744.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.11 B-76.89%๐Ÿ‡บ๐Ÿ‡ธ USA